$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

The usefulness of a novel fully automated PCR-based Idylla test for detection of the BRAF V600E mutation in thyroid tissue: comparison with PNA-clamping PCR, real-time PCR and pyrosequencing

Journal of clinical pathology, v.70 no.3, 2017년, pp.260 - 265  

Yeo, Min-Kyung (Department of Pathology and Medical Science, Chungnam National University School of Medicine, , Daejeon, Korea) ,  Jung, Min-Kyu (Department of Pathology and Medical Science, Chungnam National University School of Medicine, , Daejeon, Korea) ,  Lee, Su-Yel (Biobank of Chungnam National University Hospital, , Daejeon, Korea) ,  Lee, Yong-Moon (Department of Pathology and Medical Science, Chungnam National University School of Medicine, , Daejeon, Korea) ,  Hur, Gang Min (Department of Pharmacology, Chungnam National University School of Medicine, , Daejeon, Korea) ,  Kim, Jin-Man (Department of Pathology and Medical Science, Chungnam National University School of Medicine, , Daejeon, Korea)

Abstract AI-Helper 아이콘AI-Helper

Introduction The BRAF V600E mutation is the most common genetic event in papillary thyroid carcinoma (PTC). The BRAF V600E mutational status has a significant diagnostic and prognostic role in PTC since it can be detected in 32%-87% of PTC by various molecular methods. Aim(s) A novel, fully automate...

주제어

참고문헌 (23)

  1. Oncogene Dhillon 26 3279 2007 10.1038/sj.onc.1210421 MAP kinase signalling pathways in cancer 

  2. Ann Transl Med Karachaliou 3 265 2015 Melanoma: oncogenic drivers and the immune system 

  3. Proc Natl Acad Sci USA Franco 108 1615 2011 10.1073/pnas.1015557108 Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice 

  4. Endocr Relat Cancer Xing 12 245 2005 10.1677/erc.1.0978 BRAF mutation in thyroid cancer 

  5. Int J Cancer Gandolfi 137 1001 2015 10.1002/ijc.28976 Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma 

  6. Ann Surg Oncol Jeong 20 759 2013 10.1245/s10434-012-2494-0 BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR 

  7. Yonsei Med J Kim 45 818 2004 10.3349/ymj.2004.45.5.818 Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population 

  8. Thyroid Jung 22 791 2012 10.1089/thy.2011.0123 Mutational patterns and novel mutations of the BRAF gene in a large cohort of Korean patients with papillary thyroid carcinoma 

  9. JAMA Otolaryngol Head Neck Surg Davies 140 317 2014 10.1001/jamaoto.2014.1 Current thyroid cancer trends in the United States 

  10. Ann Surg Oncol Toniato 15 1518 2008 10.1245/s10434-008-9859-4 Papillary thyroid carcinoma: factors influencing recurrence and survival 

  11. Am J Med Mazzaferri 97 418 1994 10.1016/0002-9343(94)90321-2 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer 

  12. Eur J Clin Invest Wang 46 146 2016 10.1111/eci.12577 Clinical impact of BRAF mutation on the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis 

  13. J Korean Med Sci Cho 29 1054 2014 10.3346/jkms.2014.29.8.1054 Clinicopathological features of rare BRAF mutations in Korean thyroid cancer patients 

  14. Oncogene Fukushima 22 6455 2003 10.1038/sj.onc.1206739 BRAF mutations in papillary carcinomas of the thyroid 

  15. Korean J Pathol Jeong 46 61 2012 10.4132/KoreanJPathol.2012.46.1.61 Detection of BRAF(V600E) mutations in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR: a comparison with direct sequencing 

  16. Am J Clin Pathol Kang 139 759 2013 10.1309/AJCPN3ULH6YWBHPH Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR 

  17. Am J Clin Pathol Lee 133 802 2010 10.1309/AJCPO3F2ENKMDTUS Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system 

  18. Health Technol Assess Snowsill 18 1 2014 10.3310/hta18580 A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome 

  19. Oncotarget Janku 6 26886 2015 10.18632/oncotarget.4723 BRAF mutation testing with a rapid, fully integrated molecular diagnostics system 

  20. Exp Mol Pathol Melchior 99 485 2015 10.1016/j.yexmp.2015.09.004 Multi-center evaluation of the novel fully-automated PCR-based Idylla BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma 

  21. Onco Targets Ther Spagnolo 8 157 2015 10.2147/OTT.S39096 BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies 

  22. Thyroid Falchook 25 71 2015 10.1089/thy.2014.0123 BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer 

  23. J Gastrointest Oncol Corcoran 6 650 2015 New therapeutic strategies for BRAF mutant colorectal cancers 

LOADING...

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로